Near-Infrared Photoimmunotherapy Targeting GPR87: Development of a Humanized Anti-GPR87 Mab and Therapeutic Efficacy on a Lung Cancer Mouse Model

Expanding the application of cancer near-infrared photoimmunotherapy

“…However, applicable target molecules expressed on some types of cancers, including lung cancers, are still under investigation. Therefore, a new target molecule for lung cancers, GPR87, expressed on various lung cancers as reported recently in EBioMedicine, might be promising for further clinical application of NIR-PIT against lung cancer because this single antibody against GPR87 could cover a large proportion of lung cancer patients [9].…”